DelveInsight’s “Chronic Urticaria Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Chronic Urticaria pipeline landscape. It covers the Chronic Urticaria pipeline drug
DelveInsight’s, “Cutaneous Lupus Erythematosus Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the Cutaneous Lupus Erythematosus
DelveInsight’s “Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug
The market dynamics for HPV+ Oropharyngeal Cancer are witnessing significant growth driven by the rising incidence of HPV-associated head and neck cancers, increasing adoption of immunotherapy, expanding use of checkpoint
The market dynamics for PSMA-Targeted Therapies are witnessing significant growth driven by the increasing prevalence of prostate cancer, rising adoption of precision oncology, growing demand for targeted radioligand therapies, and
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analysis of Clinical Trials,
The Key Sleep Apnea Companies in the market include – Apnimed, Eli Lilly and Company, Incannex Healthcare, Axsome Therapeutics/Jazz Pharmaceuticals, Bioprojet, and others. The Sleep Apnea market is expected
The Key Epidermal growth factor receptor-Non Small Cell Lung Cancer Companies in the market include – AstraZeneca, J&J Innovative Medicine, Hansoh Pharmaceutical, Cullinan Oncology/Taiho Pharmaceutical, Abbvie, Yuhan Corporation, Janssen Research
The Key Clostridium Difficile Infections Companies in the market include- Adiso Therapeutics, Deinove, Acurx Pharmaceuticals, Inc, Lumen Bioscience, Inc, Summit Therapeutics, Finch Therapeutics Group, Seres Therapeutics, Vedanta Biosciences, MGB Biopharma,
The Key Celiac Disease Companies in the market include – Takeda, AnokionSA, Mozart Therapeutics, AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical Co., Ltd., Calypso Biotech, ImmunogenX, Inc., Amgen Inc., and
